Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

PRTK Paratek Pharmaceuticals Inc

2,23

0,00 (0,00%)

Zuletzt aktualisiert: 02:00:00

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Paratek Pharmaceuticals (NASDAQ:PRTK)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Paratek Pharmaceuticals Charts.

Paratek Pharmaceuticals (NASDAQ:PRTK)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Paratek Pharmaceuticals Charts.

News Paratek Pharmaceuticals Inc

Paratek Pharmaceuticals to Present NUZYRA Data at IDWeek 2023
Donnerstag 5 Oktober 2023 (7 Monate vor) • GlobeNewswire Inc.

Form 15-12G - Securities registration termination [Section 12(g)]
Montag 2 Oktober 2023 (7 Monate vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Dienstag 26 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 21 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 21 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 21 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 21 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 21 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 21 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 21 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 21 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 21 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Weitere Paratek Pharmaceuticals Inc News-Artikel

JP Morgan Chase

Deutsche Lufthansa

BNP Paribas (QX)

Deutsche Telekom

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen